Lixumistat shows early promise as treatment for pancreatic cancer

rarecancernews.com

Factuality

Ownership

Lixumistat shows early promise as treatment for pancreatic cancer

Treatment with the once-daily oral therapy lixumistat, in addition to chemotherapy, slowed the growth of pancreatic cancer among participants with advanced disease in an early clinical trial, according to new data announced by lixumistat’s developer ImmunoMet Therapeutics. “Our study of lixumistat … in combination with [chemotherapy] shows quite encouraging clinical effects in this small … study,” Shubham Pant, MD, a trial investigator at the Un…